New cancer drug targets specific protein in advanced tumors

NCT ID NCT05719558

Recruiting now Disease control Sponsor: Astellas Pharma Global Development, Inc. Source: ClinicalTrials.gov ↗

Summary

This is the first human study of an experimental drug called ASP1002 for people with advanced solid tumors that have spread. The main goals are to find a safe dose and check for side effects. The study will enroll adults whose cancers have high levels of a protein called claudin-4 and who have already tried standard treatments. Participants will receive the drug through an IV for up to two years while doctors monitor their health and tumor response.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut
RECRUITING

Plainville, Connecticut, 06062, United States
HealthPartners Cancer Research Center
RECRUITING

Saint Paul, Minnesota, 55101, United States
Henry Ford Hospital
RECRUITING

Detroit, Michigan, 48202, United States
Icahn School of Medicine at Mount Sinai
RECRUITING

New York, New York, 10029, United States
Mary Crowley Cancer Research Center
RECRUITING

Dallas, Texas, 75251, United States
NEXT Oncology Virginia
RECRUITING

Fairfax, Virginia, 22031, United States
Norton Cancer Institute
RECRUITING

Louisville, Kentucky, 40202, United States
Prisma Health-Upstate Cancer Institute
COMPLETED

Greenville, South Carolina, 29605, United States
SCRI Oncology Partners
COMPLETED

Nashville, Tennessee, 37203, United States
Swedish Cancer Institute
RECRUITING

Edmonds, Washington, 21632, United States
University Hospitals of Cleveland
RECRUITING

Cleveland, Ohio, 44106, United States
University of Florida
RECRUITING

Gainesville, Florida, 32610, United States
University of Iowa Hospitals
RECRUITING

Iowa City, Iowa, 52242, United States
University of Texas Southwestern
COMPLETED

Dallas, Texas, 75235, United States
Yale University Cancer Center
RECRUITING

New Haven, Connecticut, 06520, United States

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMORS